Catalyst Wire Dossier Catalyst Wire Dossier

BR-TND Tablet

tenofovir disoproxil · Boryung Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BR-TND Tablet, covering 2017-01-26 to 2017-01-26. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers [Phase 1]

See pricing